chlordiazepoxide has been researched along with Parkinson Disease, Secondary in 2 studies
Chlordiazepoxide: An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.
chlordiazepoxide : A benzodiazepine that is 3H-1,4-benzodiazepine 4-oxide substituted by a chloro group at position 7, a phenyl group at position 5 and a methylamino group at position 2.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kane, FJ | 1 |
| Carranza-Acevedo, J | 1 |
| Tovar-Acosta, H | 1 |
1 trial available for chlordiazepoxide and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Clinical evaluation of the efficacy of molindone and chlordiazepoxide in anxious outpatients.
Topics: Adult; Antidepressive Agents; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depression; Femal | 1972 |
1 other study available for chlordiazepoxide and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Carbon disulfide intoxication from overdosage of disulfiram.
Topics: Adult; Brain Injuries; Carbon Disulfide; Chlordiazepoxide; Depression; Disulfiram; Electroencephalog | 1970 |